Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
| Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
|---|---|---|---|---|
| Soydas T et al. | 2024 | intact cell/cell culture, NIH/3T3 aged mouse fibroblasts | magnetic field, 50/60 Hz, also other exposures without EMF, co-exposure | - |
| Nieminen V et al. | 2024 | intact cell/cell culture, SH-SY5Y (human neuroblastoma cell line) | magnetic field, 50/60 Hz, co-exposure, also other exposures without EMF | - |
| Amirinejad M et al. | 2024 | intact cell/cell culture, A172 and T98G (human glioblastoma cells) cell lines | magnetic field, 50/60 Hz, also other exposures without EMF, co-exposure | - |
| Sendera A et al. | 2024 | intact cell/cell culture, human adipose-derived mesenchymal stem cells | magnetic field, 50/60 Hz, low frequency | - |
| Rahimi S et al. | 2023 | intact cell/cell culture, dental pulp multipotent stromal stem cells | magnetic field, signals/pulses, 50/60 Hz | - |
| Sztafrowski D et al. | 2023 | intact cell/cell culture, <i>Candida albicans</i> (strains CAF2-1 and CAF4-2) | 50/60 Hz, magnetic field, co-exposure, also other exposures without EMF | - |
| Moya-Gómez A et al. | 2023 | intact cell/cell culture, BV2 cells (immortalized murine microglial cell line), SHSY5Y cells, (immortalized human neuroblastoma cell line), primary mouse microglia and neurons, animal, mongolian gerbils <i>(Meriones unguiculatus)</i> (stroke model) | 50/60 Hz, magnetic field | - |
| Ramazi S et al. | 2023 | intact cell/cell culture, MCF-7 (human breast cancer cell line) and HFF cells (human foreskin fibroblast cells) | magnetic field, 50/60 Hz, also other exposures without EMF, co-exposure | - |
| Nguyen H et al. | 2023 | intact cell/cell culture, TK6 cells (lymphoblastoma cells) | magnetic field, 50/60 Hz | - |
| Lazzarini R et al. | 2023 | intact cell/cell culture, MDA-MB-231 cells (breast cancer cell line) and MDA-MB-231 (human breast cell line) | magnetic field, 50/60 Hz | - |
| Yahyapour R et al. | 2023 | intact cell/cell culture, T98 (glioma cell line) | 50/60 Hz, magnetic field, also other exposures without EMF | - |
| Elexpuru-Zabaleta M et al. | 2023 | intact cell/cell culture, MDA-MB-231 and MCF-7 (breast cancer cell lines) and MCF-10A (breast cell line) | magnetic field, 50/60 Hz | - |
| Mousavi Maleki NS et al. | 2022 | intact cell/cell culture, human adenocarcinoma gastric cancer cell line (AGS) | magnetic field, 50/60 Hz | - |
| Mansoury F et al. | 2022 | intact cell/cell culture, human gastric adenocarcinoma (AGS) and human normal fibroblast (Hu02) cell lines | magnetic field, 50/60 Hz | - |
| Alipour M et al. | 2022 | intact cell/cell culture, rat bone marrow-derived mesenchymal cells (BMSCs) | static magnetic field, magnetic field, 50/60 Hz, co-exposure | - |
| Nieminen V et al. | 2022 | intact cell/cell culture, MCF-7 (human breast cancer cell line) | static magnetic field, magnetic field, 50/60 Hz, co-exposure, also other exposures without EMF | - |
| Shibaki R et al. | 2022 | intact cell/cell culture, MES-SA and MES-SA/DxS cells (human uterine sarcoma cell lines) | magnetic field, 50/60 Hz, co-exposure, also other exposures without EMF | - |
| Ciecholewska-Juśko D et al. | 2022 | bacterium, <i>Pseudomonas aeruginosa</i>, <i>Staphylococcus aureus</i> | magnetic field, 50/60 Hz, low frequency, also other exposures without EMF, co-exposure | - |
| Panjali Z et al. | 2022 | intact cell/cell culture, A549 (human lung cancer cell line) | magnetic field, 50/60 Hz, also other exposures without EMF, co-exposure | - |
| Aparicio-Bautista DI et al. | 2022 | intact cell/cell culture, SH-SY5Y (human neuroblastoma cell line) | magnetic field, 50/60 Hz, low frequency | - |
| Sołek P et al. | 2022 | intact cell/cell culture, HeLa cells (human adenocarcinoma cell line) and DU 145 cells (human prostate cancer cell line) | magnetic field, signals/pulses, 50/60 Hz, also other exposures without EMF, co-exposure | - |
| Masoudi-Khoram N et al. | 2022 | intact cell/cell culture, MCF-7 and MDA-MB-231 (human breast cancer cell lines) | magnetic field, low frequency, 50/60 Hz | - |
| Heidari S et al. | 2021 | intact cell/cell culture, human adenocarcinoma gastric cancer cell line (AGS) | 50/60 Hz, magnetic field | 0.2–2 mT |
| Lim HM et al. | 2021 | intact cell/cell culture, human dental pulp stem cells | magnetic field, signals/pulses, low frequency, 50/60 Hz | 10 mT |
| Salek F et al. | 2021 | intact cell/cell culture | magnetic field, 50/60 Hz, co-exposure, also other exposures without EMF | 2.5 mT |
| Colciago A et al. | 2021 | intact cell/cell culture, HEI-193 cells (human vestibular schwannoma cell line derived from a NF2 patient) | 50/60 Hz, magnetic field | 0.1 T |
| Jedrzejczak-Silicka M et al. | 2021 | intact cell/cell culture, L929 cells (murine fibroblast cells) and HaCaT cells (human keratinocytes cell line) | magnetic field, 50/60 Hz, low frequency | 5.9–28.4 mT |
| Mansoury F et al. | 2021 | intact cell/cell culture | magnetic field, low frequency, 50/60 Hz | 0.25–2 mT |
| Cios A et al. | 2021 | intact cell/cell culture, HEK293 (kidney cells), 786-O, 769-P, and Caki1 (clear cell renal carcinoma cell lines) | magnetic field, 50/60 Hz | 4.5 mT |
| Asadian N et al. | 2021 | intact cell/cell culture, rat bone marrow-derived mesenchymal stem cells | 50/60 Hz, magnetic field | 400 µT |
| Dehghani-Soltani S et al. | 2021 | intact cell/cell culture, A172 (human glioblastoma cells) and T98 cell line | magnetic field, 50/60 Hz, signals/pulses, co-exposure, also other exposures without EMF | 7 mT |
| Kayhan H et al. | 2020 | intact cell/cell culture, human, neonatal, healthy primary dermal fibroblast and MCF7 cells (human metastatic breast cancer cells) | magnetic field, 50/60 Hz, low frequency | - |
| Xu A et al. | 2020 | - | magnetic field, 50/60 Hz, low frequency | - |
| Samiei M et al. | 2020 | intact cell/cell culture, human dental pulp stem cells | magnetic field, 50/60 Hz | 0.5–1 mT |
| Yadamani S et al. | 2020 | - | magnetic field, 50/60 Hz, also other exposures without EMF, co-exposure | - |
| García-Minguillán O et al. | 2019 | - | magnetic field, low frequency, 50/60 Hz | - |
| Mercado-Sáenz S et al. | 2019 | - | magnetic field, 50/60 Hz, signals/pulses | - |
| García-Minguillán López O et al. | 2019 | - | RF, magnetic field, low frequency, 50/60 Hz | - |
| Costantini E et al. | 2019 | intact cell/cell culture, primary human gingival fibroblasts | signals/pulses, magnetic field, 50/60 Hz | 1 mT |
| Tang JY et al. | 2019 | - | magnetic field, 50/60 Hz, low frequency, signals/pulses | - |
| Balbaa AO et al. | 2019 | - | 50/60 Hz, magnetic field, electric field, co-exposure | - |
| Saikia J et al. | 2019 | isolated bio./chem. substance, beta-amyloid protein | electric field, magnetic field, 50/60 Hz, static electric field | - |
| Consales C et al. | 2019 | - | magnetic field, 50/60 Hz | - |
| Kakikawa M et al. | 2019 | - | magnetic field, 50/60 Hz, co-exposure | - |
| Özgün A et al. | 2018 | - | magnetic field, 50/60 Hz, co-exposure | - |
| Sun C et al. | 2018 | intact cell/cell culture, mouse embryonic fibroblasts (wild type and <i>Atm</i>-deficient) | 50/60 Hz, magnetic field | 2 mT |
| Solek P et al. | 2018 | - | 50/60 Hz, magnetic field | - |
| Amiri M et al. | 2018 | intact cell/cell culture, human glioblastoma cell line (U-87) | 50/60 Hz, static magnetic field, magnetic field, co-exposure, also other exposures without EMF | - |
| Yuan LQ et al. | 2018 | intact cell/cell culture, nephroblastoma and neuroblastoma cell lines (G401, CHLA255, N2a), animal, nude mice, whole body | magnetic field, static magnetic field, 50/60 Hz | - |
| Han Q et al. | 2018 | - | magnetic field, 50/60 Hz, co-exposure | - |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.
